Toxicity of lunar dust simulant exposure via the digestive system: Microbiota dysbiosis and multi-organ injury.
10.11817/j.issn.1672-7347.2025.250412
- Author:
Yixiao CHEN
1
,
2
;
Yiwei LIU
1
,
3
;
Shiyue HE
4
;
Xiaoxiao GONG
4
;
Qiyun CHENG
5
;
Ya CHEN
1
;
Xinyue HU
4
;
Zhenxing WANG
1
,
6
;
Hui XIE
1
,
7
Author Information
1. Department of Orthopaedic Surgery, Xiangya Hospital, Central South University, Changsha
2. 238111114@csu.edu.cn.
3. liuywxy@csu.edu.cn.
4. Department of Respiratory and Critical Care Medicine, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha
5. Department of Pathology, Xiangya School of Basic Medical Sciences, Central South University, Changsha
6. wangzx@csu.edu.cn.
7. huixie@csu.edu.cn.
- Publication Type:Journal Article
- Keywords:
gut microbiota;
intestinal barrier;
lunar dust simulant;
lunar exploration;
osteoporosis;
pneumonia
- MeSH:
Animals;
Dust;
Mice;
Mice, Inbred C57BL;
Dysbiosis/etiology*;
Female;
Gastrointestinal Microbiome/drug effects*;
Moon;
Liver/metabolism*;
Digestive System/microbiology*;
Lung/metabolism*;
Kidney
- From:
Journal of Central South University(Medical Sciences)
2025;50(8):1289-1305
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:As early as the Apollo 11 mission, astronauts experienced ocular, skin, and upper airway irritation after lunar dust (LD) was brought into the return cabin, drawing attention to its potential biological toxicity. However, the biological effects of LD exposure through the digestive system remain poorly understood. This study aimed to evaluate the impact of digestive exposure to lunar dust simulant (LDS) on gut microbiota and on the intestine, liver, kidney, lung, and bone in mice.
METHODS:Eight-week-old female C57BL/6J mice were used. LDS was used as a substitute for lunar dust, and Shaanxi loess was used as Earth dust (ED). Mice were randomly divided into a phosphate buffered saline (PBS) group, an ED group (500 mg/kg), and a LDS group (500 mg/kg), with assessments at days 7, 14, and 28. Mice were gavaged once every 3 days, with body weight recorded before each gavage. At sacrifice, fecal samples were analyzed by 16S ribosomal RNA (rRNA) sequencing; inflammatory cytokine expression [interleukin (IL)-1β, IL-6, and tumor necrosis factor alpha (TNF-α)] in intestinal, liver, and lung tissues was measured by real-time reverse transcription PCR (real-time RT-PCR); hematoxylin and eosin (HE) staining was performed on lung, liver, and intestinal tissues; Periodic acid-Schiff (PAS) staining was used to assess the integrity of the intestinal mucus barrier, and immunohistochemical staining was performed to evaluate the expression of mucin-2 (MUC2). Serum biochemical tests assessed hepatic and renal function. Femoral bone mass was analyzed by micro-computed tomography (micro-CT); osteoblasts and osteoclasts were assessed by osteocalcin (OCN) and tartrate-resistant acid phosphatase (TRAP) staining. Bone marrow immune cell subsets were analyzed by flow cytometry.
RESULTS:At day 10, weight gain was slowed in ED and LDS groups. At days 22 and 28, body weight in both ED and LDS groups was significantly lower than controls (both P<0.05). LDS exposure increased microbial species richness and diversity at day 7. Compared with the PBS and ED groups, mice in the LDS group showed increased relative abundance of Deferribacterota, Desulfobacterota, and Campylobacterota, and decreased Firmicutes, with increased Helicobacter typhlonius and reduced Lactobacillus johnsonii and Lactobacillusmurinus. HE and PAS staining of the colon showed that mucosal structural disruption and goblet cell loss were more severe in the LDS group. In addition, immunohistochemistry revealed a significant downregulation of MUC2 expression in this group (P<0.05). No obvious pathological alterations were observed in liver HE staining among the 3 groups, and none of the groups exhibited notable hepatic or renal dysfunction. HE staining of the lungs in the ED and LDS groups showed increased perivascular inflammatory cell infiltration (both P<0.05).
CONCLUSIONS:LDS exposure via the digestive route induces gut dysbiosis, intestinal barrier disruption, pulmonary inflammation, bone loss, and bone marrow immune imbalance. These findings indicate that LD exposure poses potential health risks during future lunar missions. Targeted restoration of beneficial gut microbiota may represent a promising strategy to mitigate LD-related health hazards.
